生命科学资讯

Anthropic, Roche & NVIDIA: This Week's Top Stories - Healthcare Digital

Roche: Making Preventative Healthcare Accessible to All - Healthcare Digital

Chutes & Ladders—Former Roche oncology head turns to Tubulis

Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com

Roche returns to Chinese biotech MediLink for another ADC pact

Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News

Roche divulges new NLRP3 inflammasome inhibitors

Roche returns to MediLink with promise of $570M near-term payments for another ADC

Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech

Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial

Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C

In Structure licensing deal, Roche commits $100M to shore up GLP-1 position

In Structure licensing deal, Roche commits $100M to shore up GLP-1 position - Fierce Biotech

Roche's patent deal with Structure; AstraZeneca reports lupus data

Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement - BioSpace

AI-based Digital Pathology Market Intelligence Report, 2025-2035, Featuring Aiforia Technologies, Ibex Medical Analytics, Indica Labs, PathAI, Roche, Visiopharm and Many Other Key Players - ResearchAndMarkets.com - The AI Journal

Emerson and Roche Collaborate on Digital Modality Library for Pharmaceutical Development - Automation World

Gilead's herpes deal; FDA approvals for Boehringer, Roche

Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma - Medical Dialogues

ROG.SW News Today: Trump Drug Plan Boosts Roche Stock on December 22 - Meyka